Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunity.

Cancer biotherapy & radiopharmaceuticals - 1 Apr 2006

Hao Siguo, Ye Zhenmin, Yang Jicheng, Bai Ou, Xiang Jim

Abstract excerpt

Because dendritic cell (DC)-derived exosomes (EXO) harbor many important DC molecules involved in inducing immune responses, EXO-based vaccines have been extensively used to induce antitumor immunity in different animal tumor models. However, it is not clear which route of EXO administration can induce more efficient antitumor immune responses. In this study, we compared the antitumor immunity derived from EXO...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to Cell Movement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Immunotherapy

Share to Injections, Subcutaneous

Share to Thymoma

Share to Thymus Neoplasms

Share to Transport Vesicles

Source

Identifiers

PMID: 16706635
DOI: 10.1089/cbr.2006.21.146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunity.PMID 16706635Read ↗

Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities.Semantic proximity Read ↗

A novel role of exosomes in the vaccination approachSemantic proximity Read ↗

Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.Semantic proximity Read ↗

Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.Semantic proximity Read ↗

Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapySemantic proximity Read ↗

In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapySemantic proximity Read ↗

Dendritic Cell‐Based Immunotherapy: The Importance of Dendritic Cell MigrationSemantic proximity Read ↗

Exosome from chaperone-rich cell lysates-loaded dendritic cells produced by CELLine 1000 culture system exhibits potent immune activity.Semantic proximity Read ↗

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of AdministrationSemantic proximity Read ↗

Glycyrrhiza uralensis polysaccharides as a DC-based Vaccine Adjuvant: Enhanced Immunotherapy Combined with PD-1 BlockadeSemantic proximity Read ↗

Glycyrrhiza uralensis polysaccharides as a Dendritic Cell-Based Vaccine Adjuvant: Enhanced Cancer Immunotherapy Combined with PD-1 BlockadeSemantic proximity Read ↗

Dendritic cell vaccines in melanoma: from promise to proof?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.